Uncategorised - European Medical Journal

Overcoming Cefiderocol AST Challenges in MDR-GN Infections: A Stepwise Approach

Inappropriate and delayed appropriate antibiotic therapy has a major impact on survival.1,2Antimicrobial susceptibility results obtained as…

Epigenetic Aging Biomarkers Could Advance Healthy Longevity

Epigenetic aging biomarkers predicted lower intrinsic capacity across adulthood, supporting their future role in precision medicine and personalised healthy aging interventions.

EASL 2026: Ana Lleo on Autoimmune Liver Disease

I must say that, initially, it was random. I was unsure what I wanted to do, but I loved internal medicine. When I did my rotation in…

Shared Decision-Making Gaps Persist in Inherited Bleeding Disorders

Patients with inherited bleeding disorders remain uncertain when comparing treatment options, highlighting opportunities to strengthen shared decision making.

Rethinking Parkinson’s Disease: Interview with Angelo Antonini

For decades, we treated Parkinson’s as if it were strictly an isolated issue in the substantia nigra. But if you actually sit in the clinic…

The ART Conceived Pregnancy: Risks and Evolving Concept

The ART Conceived Pregnancy: Risks and Evolving Concepts

Assisted reproductive technologies (ART) have transformed infertility treatment from a medical intervention into a global standard of…

Mesoglycan Shows Long-Term Promise After Superficial Vein Thrombosis

A clinical trial suggests mesoglycan may reduce long-term recurrence of superficial vein thrombosis, though larger studies are needed to confirm the benefit.

Wildfire Smoke Pollution Linked to Increased Migraines

New research from across a large cohort study in Canada has found that worsened migraine symptoms were associated with particle PM2.5, a component of wildfire smoke.

AstraZeneca's HSCT-TMA drug misses main goal in latest trial

AstraZeneca's HSCT-TMA drug misses main endpoint

A phase 3 trial of ravulizumab fell short in adult HSCT-TMA patients, while paediatric results held more promise.

Senior woman holding his painful wrist with arthritis inflammation.

GLP-1 Receptor Agonists in Psoriatic Arthritis Reduce Symptoms

New real-world evidence shows that GLP-1 receptor agonists significantly reduce joint pain and inflammation in psoriatic arthritis.